Robust response-guided dosing

被引:2
|
作者
Sinha, Saumya [1 ]
Kotas, Jakob [1 ]
Ghate, Archis [2 ]
机构
[1] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA
[2] Univ Washington, Ind & Syst Engn, Box 352650, Seattle, WA 98195 USA
基金
美国国家科学基金会;
关键词
Stochastic dose-response; Robust Markov decision processes; Medical treatment planning;
D O I
10.1016/j.orl.2016.03.012
中图分类号
C93 [管理学]; O22 [运筹学];
学科分类号
070105 ; 12 ; 1201 ; 1202 ; 120202 ;
摘要
In response-guided dosing (RGD), doses are adapted to the uncertain progression of each patient's disease condition. A stochastic dynamic program was recently developed for RGD. We study its robust counterpart, where the dose response, distribution belongs to an uncertainty set. For interval uncertainty sets, we prove that it is optimal to administer higher doses in worsening disease. When a certain scaling of a nominal distribution describes the interval, optimal doses also increase in the scaling parameter. Theory is illustrated via numerical results. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:394 / 399
页数:6
相关论文
共 50 条
  • [41] Treatment of hepatitis C: How will we use viral kinetics, response-guided therapy?
    Pawlotsky J.-M.
    Current Gastroenterology Reports, 2013, 15 (2)
  • [42] Response-guided treatment of cirrhotic chronic hepatitis B patients: Multicenter prospective study
    Gu, Er-Li
    Yu, Yi-Qi
    Wang, Jia-Li
    Ji, Yan-Yan
    Ma, Xiu-Yun
    Xie, Qing
    Pan, Hong-Ying
    Wu, Shan-Min
    Li, Jun
    Chen, Cheng-Wei
    Xu, Xiao-Wei
    Wang, Yue-Er
    Yao, Guang-Bi
    Wang, Hong
    Zhang, Wen-Hong
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (02) : 653 - 660
  • [43] Role of C-reactive protein in response-guided therapy of pyogenic liver abscess
    Law, Siu-Tong
    Li, Kin Kong
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (02) : 179 - 186
  • [44] Response-guided treatment of cirrhotic chronic hepatitis B patients: Multicenter prospective study
    Er-Li Gu
    Yi-Qi Yu
    Jia-Li Wang
    Yan-Yan Ji
    Xiu-Yun Ma
    Qing Xie
    Hong-Ying Pan
    Shan-Min Wu
    Jun Li
    Cheng-Wei Chen
    Xiao-Wei Xu
    Yue-Er Wang
    Guang-Bi Yao
    Hong Wang
    Wen-Hong Zhang
    World Journal of Gastroenterology, 2015, (02) : 653 - 660
  • [45] Response-Guided Therapy an Appropriate Tool for Evaluating Treatment Protocols and Costs of Drug Therapies
    Fincham, Jack E.
    AMERICAN HEALTH AND DRUG BENEFITS, 2015, 8 (01): : 28 - 28
  • [46] Development of breast cancer therapy: biomarker-driven and response-guided approaches in a neoadjuvant setting
    Toi, Masakazu
    Masuda, Norikazu
    Ishiguro, Hiroshi
    Saji, Shigehira
    Ohno, Shinji
    Chow, Louis W. C.
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2015, 30 (02): : E252 - E253
  • [47] Closing in on the Target: Sustained Virologic Response in Hepatitis C Virus Genotype 1 Infection Response-Guided Therapy
    Lontok, Erik
    Mani, Nina
    Harrington, Patrick R.
    Miller, Veronica
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (10) : 1466 - 1470
  • [48] Response-guided therapy by hepatitis B surface antigen level for peginterferon therapy: What is next?
    Chan, Henry Lik-Yuen
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (03) : 420 - 421
  • [49] Pretreatment prediction of the outcome of response-guided peginterferon-α and ribavirin therapy for chronic hepatitis C
    Masaki, Naohiko
    Sugiyama, Masaya
    Shimada, Noritomo
    Tanaka, Yasuhito
    Nakamuta, Makoto
    Izumi, Namiki
    Watanabe, Sumio
    Tsubota, Akihito
    Komatsu, Masafumi
    Masaki, Tsutomu
    Enomoto, Nobuyuki
    Yoneda, Masashi
    Murata, Kazumoto
    Ito, Kiyoaki
    Koike, Kazuhiko
    Mizokami, Masashi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (12) : 1996 - 2005
  • [50] Response-guided therapy for patients with hepatitis C virus genotype 6 infection: a pilot study
    Tangkijvanich, P.
    Komolmit, P.
    Mahachai, V.
    Poovorawan, K.
    Akkarathamrongsin, S.
    Poovorawan, Y.
    JOURNAL OF VIRAL HEPATITIS, 2012, 19 (06) : 423 - 430